"HLA-DR2 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad specificity HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*01:15 and DRB1*01:16 alleles.
Descriptor ID |
D015802
|
MeSH Number(s) |
D12.776.395.550.509.400.440.400.020 D12.776.543.550.440.400.440.400.020 D23.050.301.500.400.400.440.400.020 D23.050.301.500.450.400.440.389.750 D23.050.705.552.410.400.440.389.020 D23.050.705.552.450.400.440.389.750
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "HLA-DR2 Antigen".
Below are MeSH descriptors whose meaning is more specific than "HLA-DR2 Antigen".
This graph shows the total number of publications written about "HLA-DR2 Antigen" by people in this website by year, and whether "HLA-DR2 Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA-DR2 Antigen" by people in Profiles.
-
Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4. Cell Immunol. 2018 09; 331:38-48.
-
Use of human bronchial epithelial cells (BEAS-2B) to study immunological markers resulting from exposure to PM(2.5) organic extract from Puerto Rico. Toxicol Appl Pharmacol. 2010 Mar 15; 243(3):381-9.
-
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood. 2002 Sep 01; 100(5):1570-4.
-
Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J Immunol. 2001 Jun 01; 166(11):6720-7.
-
Heterophile anti-mouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for type 1A diabetes. Diabetes. 1999 Nov; 48(11):2166-70.
-
Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Int Immunol. 1998 Jul; 10(7):991-8.
-
HIV envelope protein is recognized as an alloantigen by human DR-specific alloreactive T cells. Hum Immunol. 1992 May; 34(1):31-8.
-
Relationship of hypergammaglobulinemia, circulating immune complexes, and histocompatibility antigen profiles in patients with cystic fibrosis. Am Rev Respir Dis. 1989 Dec; 140(6):1636-9.
-
Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series. Arch Neurol. 1988 Oct; 45(10):1108-11.
-
Evaluation of central nervous system involvement in uncomplicated optic neuritis after prolonged follow-up. Acta Neurol Scand. 1987 Aug; 76(2):147-51.